Rockwell Medical, Inc. (RMTI) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Rockwell Medical reported revenue of $69.3M, down 31.8% from $101.5M the year before. Net income was -$5.3M (a -7.7% net margin), or -$1.50 per diluted share. Gross margin was 16.9% and operating margin was -6.8%. Operating activities generated -$659,000 of cash, leaving -$700,000 of free cash flow. At fiscal year end, Rockwell Medical held $57.1M in total assets against $20.2M in total liabilities, including $10.7M of cash and equivalents.
Open the full interactive Rockwell Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Rockwell Medical Key Stats
| Share Price | $7.85 |
|---|---|
| Market Cap | $31.1M |
| Revenue YoY Growth | -31.8% |
| 52-Week Range | $5.19 – $12.60 |
| Shares Outstanding | 4.0 million (basic, 2026 Q2) |
Rockwell Medical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $62.2M | $61.9M | $72.8M | $83.6M | $101.5M | $69.3M |
| Cost of Goods Sold | $59.5M | $64.4M | $68.7M | $74.9M | $84.0M | $57.6M |
| Gross Profit | $2.7M | -$2.4M | $4.1M | $8.7M | $17.5M | $11.7M |
| Operating Income | -$28.4M | -$30.3M | -$16.8M | -$6.7M | $608,000 | -$4.7M |
| Pre-Tax Income | -$30.9M | -$32.7M | -$18.7M | -$8.4M | -$480,000 | -$5.3M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$30.9M | -$32.7M | -$18.7M | -$8.4M | -$480,000 | -$5.3M |
| Diluted EPS | -$45.10 | -$38.50 | -$18.90 | -$3.70 | -$0.30 | -$1.50 |
Rockwell Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $15.9M | $18.3M | $17.3M | $17.8M |
| Net Income | -$1.8M | -$554,000 | -$1.6M | -$1.2M |
| Diluted EPS | -$0.50 | -$0.02 | -$0.40 | -$0.30 |
Rockwell Medical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $48.7M | $13.3M | $10.1M | $9.0M | $15.7M | $10.7M |
| Current Assets | $69.5M | $35.3M | $35.3M | $28.8M | $37.0M | $38.2M |
| Total Assets | $77.7M | $48.6M | $46.6M | $52.2M | $59.2M | $57.1M |
| Current Liabilities | $12.8M | $21.0M | $17.7M | $16.6M | $14.1M | $9.6M |
| Total Long-Term Debt | $20.9M | $20.6M | $9.2M | $8.3M | $8.5M | $8.8M |
| Total Liabilities | $43.6M | $46.0M | $32.5M | $30.9M | $26.6M | $20.2M |
| Shareholders' Equity | $34.2M | $2.5M | $14.1M | $21.3M | $32.6M | $37.0M |
Rockwell Medical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$29.6M | -$33.5M | -$17.4M | -$9.4M | $4.2M | -$659,000 |
| Cash From Investing | $3.2M | $311,000 | -$2.4M | -$3.0M | -$4.9M | -$8.5M |
| Cash From Financing | $63.3M | -$2.2M | $16.6M | $11.3M | $7.3M | $4.3M |
| Free Cash Flow | -$29.6M | -$33.5M | -$17.4M | -$9.4M | $4.2M | -$700,000 |
Figures from Rockwell Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Rockwell Medical financials page for every line item.
Rockwell Medical Company Profile
| Ticker | RMTI |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Wixom, Michigan |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001041024 |
Frequently Asked Questions
What was Rockwell Medical's revenue in fiscal 2025?
Rockwell Medical (RMTI) reported revenue of $69.3M for fiscal 2025.
What is Rockwell Medical's annual revenue history?
Rockwell Medical's annual revenue by fiscal year: 2020: $62.2M; 2021: $61.9M; 2022: $72.8M; 2023: $83.6M; 2024: $101.5M; 2025: $69.3M.
What was Rockwell Medical's net income in fiscal 2025?
Rockwell Medical reported net income of -$5.3M for fiscal 2025.
What was Rockwell Medical's earnings per share (EPS) in fiscal 2025?
Rockwell Medical's diluted EPS was -$1.50 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Rockwell Medical generate in fiscal 2025?
Rockwell Medical generated -$700,000 of free cash flow in fiscal 2025.
What was Rockwell Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Rockwell Medical reported revenue of $17.8M.
How much debt does Rockwell Medical have?
Rockwell Medical reported $8.8M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Rockwell Medical are outstanding?
Rockwell Medical reported a weighted average of 4.0 million basic shares outstanding in 2026 Q2.
What is Rockwell Medical's market cap?
Based on its latest closing price, Rockwell Medical (RMTI) has a market capitalization of about $31.1M.
When does Rockwell Medical's fiscal year end?
Rockwell Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Rockwell Medical headquartered?
Rockwell Medical lists its business address in Wixom, Michigan in its SEC filings.